comparemela.com

Latest Breaking News On - Ultrasound parallel beam - Page 4 : comparemela.com

Main Line Dermatology Now Offers The Next Evolution Non-Invasive Anti-Aging Treatment For Fine Lines And Wrinkles: Sofwave™

Main Line Dermatology Now Offers The Next Evolution Non-Invasive Anti-Aging Treatment For Fine Lines And Wrinkles: Sofwave™
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Main Line Dermatology Now Offers The Next Evolution Non-Invasive Anti-Aging Treatment For Fine Lines And Wrinkles: Sofwave™

Main Line Dermatology Now Offers The Next Evolution Non-Invasive Anti-Aging Treatment For Fine Lines And Wrinkles: Sofwave™
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Roxana Barad, M D Announces The Newest Non-invasive Anti-Aging Treatment to Hit the Market for Fine Lines and Wrinkles Now Offered at Aesthetic Skin & Laser Center

Roxana Barad, M D Announces The Newest Non-invasive Anti-Aging Treatment to Hit the Market for Fine Lines and Wrinkles Now Offered at Aesthetic Skin & Laser Center
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Sofwave™ Medical Raises $50M and Completes Initial Public Offering on the Tel Aviv Stock Exchange

Sofwave Medical Raises $50M and Completes Initial Public Offering on the Tel Aviv Stock Exchange

Sofwave Medical Raises $50M and Completes Initial Public Offering on the Tel Aviv Stock Exchange The Medical Aesthetic company which developed an innovative approach to wrinkle reduction raises $50 million in an initial public offering. TUSTIN, Calif., June 3, 2021 /PRNewswire/ On Wednesday, May 26, 2021, Sofwave Medical made its initial public offering (IPO) on the Tel Aviv Stock Exchange (TASE). Sofwave s, rapid market adoption enabled the listing on the Tel Aviv Stock Exchange. The company managed to raise $50 million at a pre-money valuation of ~$200 million. The IPO was led by Barak Capital Underwriters. Sofwave TM is an emerging leader of energy-based non-invasive skin treatment aesthetic medical devices. The company is one of the only companies in the field of aesthetic medicine that is listed on TASE. The company has developed

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.